UHLMANN PRICE SECURITIES’s AstraZeneca AZN Stock Holding History

UHLMANN PRICE SECURITIES’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$332K	Sell	1,751 -250	-12%	-$47K	0.01%	201
2026 Q1	$388K	Buy	2,001 +601	+43%	+$116K	0.03%	157
2025 Q4	$257K	Hold	1,400	–	–	0.15%	146
2025 Q3	$215K	Buy	+1,400	New	+$212K	0.13%	165
2025 Q2	–	Sell	-1,400	Closed	-$206K	–	189
2025 Q1	$206K	Buy	+1,400	New	+$203K	0.15%	156
2024 Q4	–	Sell	-1,400	Closed	-$218K	–	180
2024 Q3	$218K	Buy	+1,400	New	+$226K	0.17%	148

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UHLMANN PRICE SECURITIES's AZN Position: Q2 2026 in Review

UHLMANN PRICE SECURITIES reduced its AstraZeneca (AZN) stake by 12% in Q2 2026, selling an estimated $47K and leaving 1,751 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #201.

UHLMANN PRICE SECURITIES first reported a position in AZN in Q3 2024 and has held it in 6 quarters since. The position peaked at $388K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

UHLMANN PRICE SECURITIES held 1,751 shares of AstraZeneca worth $332K as of Q2 2026.
UHLMANN PRICE SECURITIES sold 250 AstraZeneca shares in Q2 2026, an estimated $47K.
AstraZeneca made up 0.01% of UHLMANN PRICE SECURITIES's portfolio in Q2 2026, its #201 holding.
UHLMANN PRICE SECURITIES first reported a position in AstraZeneca in Q3 2024 and has held it in 6 quarters since.
UHLMANN PRICE SECURITIES's AstraZeneca position peaked at $388K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on UHLMANN PRICE SECURITIES's 13F filing for Q2 2026, filed 24 Jul 2026.